Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid, DxS Expand Scorpions License to Include Diagnostics

NEW YORK, Nov. 29 (GenomeWeb News) - Cepheid has licensed DxS' real-time PCR technology for use in the human in vitro diagnostics market, the company said today.


Cepheid originally licensed the probe technology, called Scorpions, in July for all markets except clinical diagnostics, wine production, and the detection of chemicals used in agriculture.


Cepheid said the product could be applicable to its SmartCycler and GeneXpert systems.


Financial details were not disclosed.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.